Jennison Associates’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.7M Buy
+499,410
New +$19.5M 0.01% 344

Other funds holding TRAX

Jennison Associates's TRAX Position: Q3 2026 in Review

Jennison Associates opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 499,410 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #344 among its holdings.

182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Jennison Associates held 499,410 shares of First Tracks Biotherapeutics worth $17.7M as of Q3 2026.
  • First Tracks Biotherapeutics was a new Jennison Associates position in Q3 2026.
  • First Tracks Biotherapeutics made up 0.01% of Jennison Associates's portfolio in Q3 2026, its #344 holding.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.